This session will cover a critical and balanced appraisal of the major anticoagulant classes: DOACs, LMWH, and Vitamin K antagonists ; contextualizing their roles across VTE indications. The session focuses on practical prescribing considerations, patient-specific factors influencing drug choice, monitoring requirements, reversal strategies, and aligning therapy with guidelines and real-world clinical constraints.